NCT02583152View on ClinicalTrials.gov

New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

Mucopolysaccharidoses

Trial Locations (1)

M13 9WL

RECRUITING

Manchester Royal Eye Hospital, Manchester

Sponsors

Collaborators (1)

BioMarin Pharmaceutical

All Listed Sponsors

collaborator

BioMarin Pharmaceutical

INDUSTRY

lead

Manchester Royal Eye Hospital

OTHER